Company intelligence / Profile preview

New Wave Mode

Manchester, England, United Kingdomnewwave.se ↗

Ownership: Private
Development stage: Other

Overview

New Wave Biotech develops AI-powered software that enables biotech companies to optimize downstream processing in biomanufacturing. Their platform helps reduce R&D costs, improve yield, and accelerate commercialization by providing virtual testing and techno-economic analysis tools. The company has demonstrated significant cost reductions and process improvements for clients in synthetic biology and industrial biotech sectors.

Industry: Drug Discovery Services

Partnerships

Multus (biotechnology partner using their platform to optimize growth factor purification)

Beyond the preview

Go deeper on New Wave Mode.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Wave Mode.

Explore the full profile